Preclinical Efficacy of Clumping Factor a in Prevention ofStaphylococcus aureusInfection

mBio - United States
doi 10.1128/mbio.02232-15
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Evaluating Preclinical Efficacy

Science Translational Medicine
Medicine
2011English

Immunogenicity of Toxins duringStaphylococcus aureusInfection

Clinical Infectious Diseases
Infectious DiseasesMicrobiology
2010English

Prevention of DNA Damage and Anticarcinogenic Activity of Activia® in a Preclinical Model

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2017English

Fibrinogen Binding Sites P336 and Y338 of Clumping Factor a Are Crucial for Staphylococcus Aureus Virulence

PLoS ONE
Multidisciplinary
2008English

Efficacy of a Postoperative Infection Prevention Protocol in Spine Surgery

Global Spine Journal
OrthopedicsSurgeryNeurologySports Medicine
2016English

An Electroencephalography Bioassay for Preclinical Testing of Analgesic Efficacy

Scientific Reports
Multidisciplinary
2018English

Preclinical Study of rAAV2-sTRAIL: Pharmaceutical Efficacy, Biodistribution and Safety in Animals

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2017English

Preclinical Safety and Immunological Efficacy of Alternaria Alternata Polymerized Extracts

Immunity, inflammation and disease
AllergyImmunology
2017English

Preclinical Efficacy in Therapeutic Area Guidelines From FDA and EMA: A Cross-Sectional Study

British Journal of Pharmacology
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy